Summary
Urovant Sciences Ltd.
Founded in 1981
Description
We aim to advance patient care through bold innovation, diversity of thought, openness to ideas, adaptation to change, integrity and compassion.
Strengths
- Urovant Sciences Ltd. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Urovant Sciences Ltd. was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Annual Revenue
Urovant Sciences Ltd.'s annual revenue
$19889000
Based on Kona Equity data
-
Revenue per employee
$284128
-
Variance of revenue growth
0.04
-
Annual revenue growth since founding
$3977800
-
Revenue growth rate from first known quarter to current
136.8%
Employee Count
70 employees
-
Employee growth rate from first known quarter to current
66.7%
Executives
David Hovland
Global Senior VP, Regulatory Affairs
d**@urovant.comSarah Qaiser
Manager, Analytics
s**@urovant.comReginald Washington
Vice President, Area, Specialty Sales
r**@urovant.comJohn Castillano
Director, Commercial Manufacturing Operations
j**@urovant.comDavid Musselman
Area Vice President, Sales (East)
d**@urovant.comPaul King
Marketing Vice President, Market Access
p**@urovant.comBen Scott
Senior Territory Sales Manager
b**@urovant.comMike Porter
Regional Area - Accounts & Long Term Care & GPO Vice President, Market Access
m**@urovant.comKatie Vu
Senior Accountant
k**@urovant.comPhyllis Fichera
Senior Manager, Marketing Operations
p**@urovant.comElizabeth Minerd
Vice President, Associate General Counsel
e**@urovant.comKayla Kramer
Specialty Territory Sales Manager
k**@urovant.comDennis Horn
Senior Long Term Care Territory Manager
d**@urovant.comShobhal Patel
Head Vice President, Clinical Operations
s**@urovant.comJames Robinson
CEO
j**@urovant.comDaniel Snyder
Vice President, Medical Affairs
d**@urovant.comCornelia Haag-Molkenteller
Executive Vice President & Chief Medical Officer
c**@urovant.comWalt Johnston
Executive VP, Commercial
w**@urovant.comTed Chan
Senior Vice President, Associate General Counsel, Head of Intellectual Property
t**@urovant.comDavid Buckley
Senior Territory Manager
d**@urovant.comMatthew Banner
Senior Manager, Reporting & Analytics
m**@urovant.comRegina Pacheco
Executive Assistant
r**@urovant.comBetzy Estrada
Executive VP & Chief Human Resources Officer
b**@urovant.comRob Gnepper
Specialty Senior Territory Sales Manager
r**@urovant.comJudy Miller
Specialty Phila Senior Territory Sales Manager (East)
j**@urovant.comStewart Kenton
Executive Vice President, Market Access
s**@urovant.comPhone Sciences
Chief Executive Officer & President
p**@urovant.comNassi Agouridis
Vice President, Area, Specialty Sales
n**@urovant.comPratik Ahuja
Vice President, Supply Chain
p**@urovant.comRyan Card
Vice President, Associate General Counsel
r**@urovant.comG Score - 7
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.54 M
-
Page views per visitor
2.0
-
Daily time
1:31
Location
Unlock unlimited leads
Similar Companies
CymaBay Therapeutics
cymabay.com- Founded in 1990
- Location: Newark, CA
- Annual Revenue: $20.3M
- Employees: 59
- CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX...
Ascentage Pharma Group
ascentagepharma.com- Founded in 2009
- Location: Suzhou, Jiangsu
- Annual Revenue: $80.9M
- Employees: 238
- Ascentage Pharma is a global, clinical stage biotechnology company engaged in developing novel therapies for cancers, CHB, and senesce diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limit...
PhaseBio Pharmaceuticals
phasebio.com- Founded in 2002
- Location: Malvern, PA
- Annual Revenue: $10.9M
- Employees: 60
- PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Otonomy
otonomy.com- Founded in 2008
- Location: San Diego, CA
- Annual Revenue: $35.0K
- Employees: 51
- In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor v...
G1 Therapeutics
g1therapeutics.com- Founded in 2008
- Location: Durham, NC
- Annual Revenue: $24.2M
- Employees: 148
- G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina.
Landos Biopharma
landosbiopharma.com- Founded in 2017
- Location: Blacksburg, VA
- Annual Revenue: $18.0M
- Employees: 46
- Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first in class, oral therapeutics for patients with autoimmune disease. They have a portfolio of two novel targets anchoring libraries of immunometabolic modul...
Key Information
- Name: Urovant Sciences Ltd.
- Category: Biotechnology
- SIC: 28; 283
- NAICS: 62151; 42421
See similar companies
-
By City Irvine Biotechnology in Irvine Small Biotechnology in Irvine Mid-size Biotechnology in Irvine
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology G Score of 7
-
Firmographic data G Score of 7 Founded in 1981 SIC: 28 SIC: 283 NAICS: 62151 NAICS: 42421 #Drug Manufacturing & Research #Medical Testing & Clinical Laboratories #Pharmaceuticals #Healthcare
Frequently Asked Questions
Urovant Sciences Ltd.'s headquarters are located at 5281 CALIFORNIA Ave. Ste. 100 Irvine, CA 92617.
Urovant Sciences Ltd.'s official website is urovant.com
Urovant Sciences Ltd.'s annual revenue is $19.9 M.
Urovant Sciences Ltd.'s SIC: 28; 283
Urovant Sciences Ltd.'s NAICS: 62151; 42421.
Urovant Sciences Ltd. has 70 employees
Urovant Sciences Ltd. is in the industry of Biotechnology.
